Microbial Identification Market - Growth, Trends, and Forecasts (2022 - 2027)

The Microbial Identification Market is projected to witness a CAGR of 7.0% over the forecast period.

The COVID-19 outbreak has had a significant impact on the market. As employment closures have curtailed import and export activities and closures of diagnostics centers and hospitals. For instance, according to an article titled "Impact of the COVID-19 pandemic on the surveillance, prevention, and control of antimicrobial resistance: a global survey" published in September 2021, there was a reduction in the availability of the nursing, medical, and public health staff for antimicrobial resistance by 71%, 69%, and 64%, respectively. However, with the release COVID-19 restrictions and resumed diagnosis and testing services in industries the studied market is expected to grow over the forecast period.

Certain factors propelling the market growth are the rising burden of infectious diseases, technological advancements in microbial identification, increasing food safety concerns, and government initiatives and funding for promoting microbial identification.

The increasing prevalence of infectious diseases is the key factor driving market growth. For instance, according to the data published by the World Health Organization in the Global Tuberculosis Report 2021, most of the tuberculosis cases were found in the World Health Organization (WHO) regions of South-East Asia (43%), Africa (25%) and the Western Pacific (18%), and lesser numbers of tuberculosis cases were found in Eastern Mediterranean (8.3%), the Americas (3.0%) and Europe (2.3%). Similarly, according to the World Health Organization (WHO) data published in 2021, Sub-Saharan Africa likely continues to endure the burden of malaria, accounting for approximately 95% of all cases and 96% of all deaths. Thus, rising cases of infectious diseases are expected to increase the demand for microbial testing resulting in the high growth of the market.

Additionally, the growing food safety concerns in packed and non-packed food are also contributing to the market growth. The population nowadays is more shifting toward consuming processed foods which have a high risk of microbial contamination. For instance, according to an article published by Nutrition and Diabetes, in December 2020, titled 'Ultra-processed food consumption and obesity in the Australian adult population", it has been found that 80% of the adults in Australia consumed processed or junk food, such as mass-produced packaged bread, ready meals, fast food dishes and pastries, buns and cakes, in their daily life. Thus, the high consumption of this processed food by the population is expected to increase the demand for microbial testing to deliver safe and quality food to the population.

Furthermore, as per the data published by the World Health Organization in May 2022, an estimated 600 million people fall ill eating contaminated food and 420 000 die every year. In addition, USD 110 billion is lost each year in productivity and medical expenses resulting from unsafe food in low- and middle-income countries.Thus, the rising incidences of food contamination has increased the need for food testing for detecting specific microbes causing diseases.

Moreover, in 2020, the World Health Assembly passed a new resolution requiring the World Health Organization to report on the global burden of foodborne diseases by 2025 with the most recent estimates of incidence, mortality, and disease burden. The resolution mandates WHO to monitor the global burden of foodborne and zoonotic diseases at national, regional, and international levels. Such initiatives by the government are also contributing to market growth.

However, the high cost of automated microbial identification systems is likely to impede the market growth over the forecast period.

Key Market Trends

Instruments are Driving the Product and Service Segment's Growth

The instrument segment is expected to witness significant growth in the studied market over the forecast period owing to the factors such as the rising burden of infectious diseases, growing awareness regarding microbial testing, and emerging technologically advanced products.

The range of the distinguishable organism has expanded over the years to include a wider range of microorganism strains. These include techniques for rapid isolated-organism identification using mass spectrometry (MS) in clinical specimens.

With the increasing prevalence of infectious diseases, there is an increasing need to identify the microorganism causing them. For instance, as per the World Health Organization data published in July 2022, two fatal cases of Marburg virus disease (MVD) were reported from the Ashanti region, Ghana, and were later tested positive for Marburg virus. Additionally, as per a news published in April 2022, in Florida, there has been a significant serogroup C meningococcal disease outbreak, mostly affecting men who have intercourse with other men, including those who are HIV-positive.

Additionally, the rising company activities in developing microbial testing products are also expected to boost segment growth over the forecast period. For instance, in July 2021, Bruker Corporation launched new products and methods for the MALDI Biotyper (MBT) platform, MALDI Biotyper Sirius, that supports workflows for the rapid, nearly universal and cost-effective microbial identification by 'proteomic fingerprinting' from culture plates and from positive blood cultures. Also, in April 2021, bioMerieux received CE-marking of VITEK MS PRIME, the next generation of the VITEK MS MALDI-TOF mass spectrometry system for routine microbial identification in minutes.

Thus, owing to the aforementioned factors, the studied market is expected to grow over the forecast period.

North America Accounts for the Largest Share in the Market

North America is expected to dominate the microbial identification market over the forecast period owing to the factors such as the rising burden of infectious diseases and outbreaks of epidemics, growing healthcare expenditure, and the presence of well-established healthcare infrastructure.

The increasing prevalence of infectious diseases in the region is the key factor fuelling the market growth. For instance,

As per the data published by the Centers for Medicare & Medicaid Services, in March 2022, titled "CMS Office of the Actuary Releases 2021-2030 Projections of National Health Expenditures", it has been observed that the annual growth in national health spending is expected to be average 5.1% over 2021-2030. Also, the National Health Spending in 2020 was USD 4.1 trillion and it is projected to reach USD 6.8 trillion by 2030. Thus, the increasing healthcare spending is expected to increase company activities and government initiatives in developing technologically advanced testing products and equipment, thereby propelling the market growth.

In addition, rising technologically advanced products and the presence of key market players in the region are also expected to boost market growth over the forecast period. For instance, in January 2022, BD received 510(k) clearance from the United States Food and Drug Administration for BD Kiestra IdentifA system which is designed to automate the preparation of microbiology bacterial identification testing. Also, in January 2021, Bruker Corporation launched MBT Sepsityper Kit US IVD for rapid microbial identification of more than 425 microorganisms from positive blood cultures on the MALDI Biotyper CA System.

Thus, owing to the aforementioned factors, the studied market is expected to grow over the forecast period.

Competitive Landscape

The market studied is moderately competitive, with the presence of both global and local players. Few companies currently hold a healthy share of the market. For instance, Thermofisher Scientific, BioMerieux SA, Beckman Coulter Inc., Shimadzu Corporation, and Becton, Dickinson and Company are the major players in the market, along with local and smaller companies that hold a substantial share.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support